MorrowPE. Conference on the scientific basis of respiratory therapy: aerosol therapy. Aerosol characterization and deposition. Am Rev Respir Dis1974;110(6, Part 2):88–99.
2.
YuCP, NicolaidesP, SoongTT. Effect of random airway sizes on aerosol deposition. Am Ind Hyg Assoc J1979;40:999–1005.
3.
DolovichM, ChambersC, NewhouseM.Characterization of three systems used to deliver pentamidine (P) aerosol (abstract). Am Rev Respir Dis1990;141(4, Part 2):A153.
4.
IlowiteJS, BaskinMI, SheetzMS, AbdAG. Comparison of the delivered dose and regional distribution of aerosolized pentamidine using different delivery systems (abstract). Am Rev Respir Dis1990;141(4, Part 2):A53.
5.
MorrowPE. Factors determining hygroscopic aerosol deposition in airways. Physiol Rev1986;66:330–375.
6.
MartinGP, BellAE, MarriottC.An in vitro method for assessing particle deposition from metered pressurized aerosols and dry powder inhalers. Int J Pharm1988;44:57–63.
7.
RyanG, DolovichMB, ObminskiG, CockcroftDW, JuniperE, HargreaveFE, et al. Standardisation of inhalation provocation tests: influence of nebulizer output, particle size and method of inhalation. J Allergy Clin Immunol1981;67:156–161.
8.
DolovichMB, RuffinRE, RobertsRS, NewhouseMT. Optimal delivery of aerosols from metered dose inhalers. Chest1981;83:911–915.
9.
NewmanSP, PaviaD, ClarkeSW. How should pressurized beta-adrenergic bronchodilator be inhaled?Eur J Respir Dis1981;62:3–21.
10.
MurakamiG, IgarashiT, AdachiY, MatsunoM, AdachiY, SawaiM, et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy1990;64:383–387.
11.
NewmanSP, BatemanJRM, PaviaD, ClarkeSW. The importance of breath-holding following the inhalation of pressurized aerosol bronchodilators. In: BaranD, ed. Recent advances in aerosol therapy: first Belgian symposium on aerosols in medicine. Brussels: UCB Pharmaceuticals, 1979:117–122.
12.
AutyRM, BrownK, NealeMG, SnashallPD. Respiratory tract deposition of sodium cromoglycate is highly dependent upon technique of inhalation using the Spinhaler. Br J Dis Chest1987;81:371–380.
13.
PedersenS.How to use a Rotahaler. Arch Dis Child1986;61:11–14.
14.
VidgrenM, ParonenP, VidgrenP, VainioP, NuutinenJ.In-vivo evaluation of the new multiple dose powder inhaler and Rotahaler using gamma scintigraphy. Acta Pharm Nord1990;1:3–10.
15.
PerssonG, GruvstadE, StahlE.A new multiple dose powder inhaler (Turbuhaler) compared with a pressurized inhaler in a study of terbutaline in asthmatics. Eur Respir J1988;1:681–684.
16.
DolovichM, VanzieleghemM, HidingerK-G, NewhouseMT. Influence of inspiratory flow rate on the response to terbutaline sulphate inhaled via the Turbuhaler (abstract). Am Rev Respir Dis1988;137(4, Part 2):433.
17.
SantolicandroA, RuschiS, FornaiE, GiuntiniC.Imaging of ventilation in chronic obstructive pulmonary disease. J Thorac Imag1986;1:36–53.
18.
MonrigalJP, GranryJC, VilayleckS, LejeuneJJ, ChavellatM.Effects of the endotracheal state on the progression of antibiotics administered by aerosol route (abstract). Am Rev Respir Dis1990;141(4, Part 2):A525.
19.
XuJB, YuCP. The effects of age on deposition of inhaled aerosols in the human lung. Aerosol Sci Technol1986;5:349–357.
20.
DolovichMB, SanchisJ, RossmanC, NewhouseMT. Aerosol penetrance: a sensitive index of peripheral airways obstruction. J Appl Physiol1976;40:468–471.
21.
IlowiteJS, GorvoyJD, SmaldoneGC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis1987;136:1445–1449.
22.
KimCS, LewarsGA, SacknerMA. Measurement of total lung aerosol deposition as an index of lung abnormality. J Appl Physiol1988;64:1527–1536.
23.
ChanTL, LippmannM.Experimental measurement and empirical modelling of the regional deposition of inhaled particles in humans. Am Ind Hyg Assoc J1980;41:399–409.
O'DohertyMJ, ThomasSH, PageCJ, BradbeerC, NunanTO, BatemanNT. Does inhalation of pentamidine in the supine position increase deposition in the upper part of the lung?Chest1990;97:1343–1348.
26.
SalzmanGS, PyszczynskiDR. Oral pharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. J Allergy Clin Immunol1988;81:424–428.
27.
DolovichM, RuffinR, CorrD, NewhouseM.Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest1983;84:36–44.
28.
NewmanSP, MillarAB, Lennard-JonesTR, MorenF, ClarkeSW. Improvement of pressurized aerosol deposition with Nebuhaler spacer device. Thorax1984;39:935–941.
29.
KönigP, GayerD, KantakA, KreutzC, DouglassB, HordvikNL. A trial of metaproterenol by metered-dose inhaler and two spacers in preschool asthmatics. Pediatr Pulmonol1988;5:247–251.
30.
FullerHD, DolovichMB, PosmituckG, Wong PackW, NewhouseMT. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients: comparison of dose to the lungs. Am Rev Respir Dis1990;141:440–444.
31.
FlavinM, MacDonaldM, DolovichM, CoatesG, O'BrodovichH.Aerosol delivery to the lung with an infant ventilator. Pediatr Pulmonol1986;2:36–39.
32.
MacIntyreNR, SilverRM, MillerCW, SchulerF, ColemanRE. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med1985;13:81–84.
33.
DolovichM.Lung deposition of aerosols: methods and assessments. In: EpsteinSW, ed. Metered dose inhalers. Proceedings of an international workshop. Mississauga, Canada: Astra Pharmaceuticals, 1984:27–37.
34.
BrainJD, ValbergPA. Deposition of aerosols in the respiratory tract. Am Rev Respir Dis1979;120:1325–1373.
35.
JuniperEF, KlinePA, VanzieleghemMA, RamsdaleEH, O'ByrnePM, HargreaveFE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in non-steroid-dependent asthmatics. Am Rev Respir Dis1990;142:832–836.
36.
HowarthPH, DjukanovicR, WilsonJ, WilsonS, BrittenK, RocheW, et al. Airway inflammation and asthma: the influence of inhaled beclomethasone dipropionate. Clin Exp Allergy1990;20(1, Suppl):94.
